Lipid-based Polyene Antifungal [EPC]

9839 reported adverse events

Drugs of this class: AMPHOTERICIN B AMPHOTERICIN B, DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL- AND DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL-

These side effects are most commonly reported by patients taking drugs of the Lipid-based Polyene Antifungal [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 1569
1 OFF LABEL USE 706
2 PYREXIA 616
3 SEPSIS 419
4 HYPOKALAEMIA 403
5 FEBRILE NEUTROPENIA 394
6 PNEUMONIA 387
7 RENAL FAILURE 356
8 CONDITION AGGRAVATED 332
9 RENAL IMPAIRMENT 332
See all common reactions for Lipid-based Polyene Antifungal [EPC]

Drugs of the Lipid-based Polyene Antifungal [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SPLENIC CANDIDIASIS 7 0.3333
1 CAROTID ARTERY INSUFFICIENCY 6 0.2400
2 PYELONEPHRITIS FUNGAL 7 0.2188
3 RHINOCEREBRAL MUCORMYCOSIS 8 0.2162
4 OSTEOMYELITIS FUNGAL 14 0.1750
5 HEPATOSPLENIC CANDIDIASIS 17 0.1700
6 CHOROIDITIS 35 0.1613
7 GEOTRICHUM INFECTION 21 0.1500
8 PNEUMONIA MORAXELLA 7 0.1489
9 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 13 0.1477
See all enriched reactions for Lipid-based Polyene Antifungal [EPC]